P3 Health Partners Inc.

NASDAQ: PIII · Real-Time Price · USD
6.70
-0.24 (-3.48%)
At close: Aug 15, 2025, 3:57 PM
6.78
1.12%
After-hours: Aug 15, 2025, 04:10 PM EDT

P3 Health Partners Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.49B 1.5B 1.48B 1.4B 1.35B 1.27B 1.18B 1.14B 1.08B 1.05B 491.4B 491.3B 491.19B 491.06B 589.64M 561.96M 527.4M
Cost of Revenue
1.51B 1.54B 1.16B 1.46B 1.42B 1.32B 1.22B 1.2B 1.14B 1.12B 1.5B 1.38B 1.27B 1.13B 594.58M 560.27M 515.66M
Gross Profit
-27.75M -37.08M 318.55M -56.16M -65.11M -55.04M -45.57M -61.31M -64.34M -73.33M 489.9B 489.92B 489.92B 489.94B -4.94M 1.69M 11.74M
Operating Income
-314.92M -320.66M -246.41M -173.25M -162.94M -167.93M -640.17M -666.36M -1.56B -1.56B -963.82M -931.93M -39.18M n/a -64.83M -50.22M -35.45M
Interest Income
322K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.34M 6.66M 6.66M
Pretax Income
-301.63M -305.99M -249.13M -179.56M -179.11M -183.73M -646.89M -675.34M -1.55B -1.56B -32.36B -32.33B -31.45B -31.41B -84.01M -65.68M -47.67M
Net Income
-137.63M -135.85M -102.69M -69.48M -67.27M -57.77M -126.34M -124.21M -268.75M -270.13M -100.01M -120.89M 3.99M -10.08M -89.85M -74.5M -49.22M
Selling & General & Admin
111.38M 113.93M 107.25M 113.62M 114.67M 125.59M 141.84M 147.11M 161.53M 162.35M 54.96B 54.94B 54.92B 54.89B 72.49M 65.59M 58.76M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
944.55M 936.42M 462.4M 20.83M 1.79M 315.04M 601.6M 870.7M 872.93M 846.93M 464.85B 464.58B 464.58B 464.29B n/a n/a n/a
Operating Expenses
1.06B 1.05B 564.97M 418.02M 722.82M 1.04B 1.35B 1.34B 1.32B 1.3B 520.1B 519.97B 519.81B 519.65B 521.06M 351.76M 302.43M
Interest Expense
26.64M 22.17M 19.39M 17.74M 16.16M 15.98M 15.1M 14.06M 12.91M 11.58M 12.08M 11.64M 11.31M 10.67M 7.02M 4.49M 2.12M
Selling & Marketing Expenses
1.19M 1.33M 1.59M 2.11M 2.55M 3.23M 4.21M 4.68M 5.23M 5.09M 1.5B 1.5B 1.5B 1.5B 1.99M 1.78M 1.57M
Cost & Expenses
1.8B 1.82B 1.72B 1.58B 1.52B 1.43B 1.35B 1.34B 1.32B 1.3B 520.1B 519.97B 519.81B 519.65B 657.3M 615.02M 565.69M
Income Tax Expense
3.39M 4.39M 1.2M 5.22M 4.48M 2.69M 2.83M -48.99M -795.24M -842.98M -858.51M -803.18M -47.13M 323.44K 17.41M 13.48M 3.45M
Shares Outstanding (Basic)
3.26M 3.25M 3.24M 2.73M 2.32M 2.31M 2.28M 2.15M 831.58K 831.58K 831.58K 831.58K 831.58K 831.58K 807.27K 807.27K 790.63K
Shares Outstanding (Diluted)
3.26M 3.25M 3.29M 2.82M 2.36M 2.31M 2.23M 2.15M 831.58K 831.58K 831.58K 831.58K 831.58K 831.58K 807.27K 807.27K 790.63K
EPS (Basic)
-43.07 -44.87 -37.89 -29.34 -29.51 -32.49 -134.52 -142.14 -323.18 -324.84 -398.92 -379.47 -206.89 -188.08 -0.94 -28.08 -18.2
EPS (Diluted)
-50.17 -51.81 -42.03 -32.29 -25.01 -28.15 -130.18 -137.66 -324.12 -325.78 -399.86 -380.41 -194.12 -181.28 5.87 -21.27 -24.17
EBITDA
-189.42M -197.76M -143.21M -75.23M -76.28M -81.07M -544.72M -574.33M -1.45B -1.46B -1.14B -1.13B -273.25M -249.62M -69.96M -55.57M -34.5M
EBIT
-274.99M -283.82M -229.75M -161.82M -162.95M -167.75M -631.76M -661.25M -1.54B -1.55B -1.21B -1.18B -305.74M -260.69M -72.49M -57.88M -35.45M
Depreciation & Amortization
85.57M 86.06M 86.54M 86.59M 86.67M 86.67M 87.04M 87.14M 87.08M 87.29M 74.01M 52.65M 31.36M 9.94M 1.4M 1.19M 948.72K